"Chemoradiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Combined chemotherapy and radiotherapy given to augment some other form of treatment such as surgery. It is commonly used in the therapy of cancer.
- Chemoradiotherapy, Adjuvant
- Adjuvant Chemoradiotherapies
- Chemoradiotherapies, Adjuvant
- Adjuvant Radiochemotherapy
- Adjuvant Radiochemotherapies
- Radiochemotherapies, Adjuvant
- Radiochemotherapy, Adjuvant
- Adjuvant Chemoradiotherapy
Below are MeSH descriptors whose meaning is more general than "Chemoradiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Chemoradiotherapy, Adjuvant".
This graph shows the total number of publications written about "Chemoradiotherapy, Adjuvant" by people in this website by year, and whether "Chemoradiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Chemoradiotherapy, Adjuvant" by people in Profiles.
Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer. JAMA Netw Open. 2020 11 02; 3(11):e2025881.
A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer. Cancer. 2020 01 15; 126(2):381-389.
Multidisciplinary Therapy of Esophageal Cancer. Surg Clin North Am. 2019 Jun; 99(3):419-437.
Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up. Breast Cancer Res Treat. 2019 Jun; 175(2):287-295.
Immune Checkpoint Inhibitor Therapy in Breast Cancer. J Natl Compr Canc Netw. 2018 10; 16(10):1259-1268.
Disparities in survival after trimodality therapy for esophageal adenocarcinoma. Dis Esophagus. 2018 Sep 01; 31(9).
Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery. 2018 05; 163(5):1047-1052.
Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study. J Gastrointest Surg. 2018 02; 22(2):214-225.
The use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update. Curr Urol Rep. 2017 Jul; 18(7):50.
The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2017 Jul 15; 123(14):2762-2772.